[article]
| Titre : |
An exploratory fetal MRI study examining the impact of 22q11.2 microdeletion syndrome on early brain growth |
| Type de document : |
texte imprimé |
| Auteurs : |
Daniel CROMB, Auteur ; Tom FINCK, Auteur ; Alexandra F. BONTHRONE, Auteur ; Alena UUS, Auteur ; Milou VAN POPPEL, Auteur ; Johannes STEINWEG, Auteur ; David F LLOYD, Auteur ; Kuberan PUSHPARAJAH, Auteur ; Reza RAZAVI, Auteur ; Serena J. COUNSELL, Auteur ; Mary. RUTHERFORD, Auteur |
| Langues : |
Anglais (eng) |
| Mots-clés : |
Humans Magnetic Resonance Imaging Female Brain/diagnostic imaging/growth & development/embryology/pathology DiGeorge Syndrome/diagnostic imaging Pregnancy Male Heart Defects, Congenital/diagnostic imaging Fetus/diagnostic imaging Adult Prenatal Diagnosis 22q deletion syndrome Fetal MRI authors declare no competing interests. Ethical approval: The National Research Ethics Service West London committee provided ethical approval (22qDS and CHD fetuses: 07/H0707/105 Control fetuses: 14/LO/1806). Informed, written consent was obtained from all participants before undergoing fetal MRI. We confirm that all methods were performed in accordance with the relevant guidelines and regulations. |
| Index. décimale : |
PER Périodiques |
| Résumé : |
BACKGROUND: Improved long-term outcomes, related to advances in surgical and clinical care of infants with congenital heart disease (CHD), has shifted focus onto the accompanying and later-onset cognitive and neuropsychiatric disorders in those who also have 22q11.2 deletion syndrome (22qDS). 22qDS is itself associated with neurodevelopmental impairments and altered brain growth. However, when brain growth in 22qDS first deviates from normal is unknown, and whether impaired brain development is primarily genetics-driven or a secondary consequence of the underlying CHD remains incompletely understood. METHODS: In this small, exploratory study, we use fetal MRI to assess volumetric brain development in 22qDS by comparing fetal brain morphometry to a set of gestation and sex-matched healthy controls, and a cohort of gestation and sex-matched fetuses with the same CHD diagnoses but without 22q11.2 deletion. Structural T2-weighted fetal brain images were acquired using a 1.5T MRI scanner. MR scanner and sequence parameters were identical in all cohorts. Motion-corrected images underwent segmentation using an automated pipeline developed for fetal brain MRI. Total brain tissue volumes, volumes for four different tissue regions (cortical grey matter, white matter, deep grey matter and cerebellum), cerebrospinal fluid and total intracranial volumes were calculated. RESULTS: Antenatal imaging was acquired between 29 and 35 weeks gestation. Thirty-three fetuses were included (7 22qDS; 14 isolated CHD; 12 healthy control). White matter volumes were significantly reduced in fetuses with 22qDS compared to control fetuses (p = 0.028), but not to those with CHD without 22q11.2 deletion (p = 0.09). Large effect-sizes were seen between the 22qDS and isolated CHD cohorts (D(Cohen) = 0.81), and between the 22qDS and control cohorts (D(Cohen) = 1.2) for white matter volumes. No significant differences were seen in volumes of other brain regions between groups. CONCLUSIONS: This exploratory study expands our existing knowledge on neurodevelopmental impairments in 22qDS to the fetal period by highlighting reduced white matter volumes compared to gestation and sex-matched control fetuses during this time-period. Our findings suggest that impaired white matter growth in fetuses with both 22qDS and CHD may not be fully explained by any underlying CHD. |
| En ligne : |
https://dx.doi.org/10.1186/s11689-025-09594-9 |
| Permalink : |
https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=576 |
in Journal of Neurodevelopmental Disorders > 17 (2025)
[article] An exploratory fetal MRI study examining the impact of 22q11.2 microdeletion syndrome on early brain growth [texte imprimé] / Daniel CROMB, Auteur ; Tom FINCK, Auteur ; Alexandra F. BONTHRONE, Auteur ; Alena UUS, Auteur ; Milou VAN POPPEL, Auteur ; Johannes STEINWEG, Auteur ; David F LLOYD, Auteur ; Kuberan PUSHPARAJAH, Auteur ; Reza RAZAVI, Auteur ; Serena J. COUNSELL, Auteur ; Mary. RUTHERFORD, Auteur. Langues : Anglais ( eng) in Journal of Neurodevelopmental Disorders > 17 (2025)
| Mots-clés : |
Humans Magnetic Resonance Imaging Female Brain/diagnostic imaging/growth & development/embryology/pathology DiGeorge Syndrome/diagnostic imaging Pregnancy Male Heart Defects, Congenital/diagnostic imaging Fetus/diagnostic imaging Adult Prenatal Diagnosis 22q deletion syndrome Fetal MRI authors declare no competing interests. Ethical approval: The National Research Ethics Service West London committee provided ethical approval (22qDS and CHD fetuses: 07/H0707/105 Control fetuses: 14/LO/1806). Informed, written consent was obtained from all participants before undergoing fetal MRI. We confirm that all methods were performed in accordance with the relevant guidelines and regulations. |
| Index. décimale : |
PER Périodiques |
| Résumé : |
BACKGROUND: Improved long-term outcomes, related to advances in surgical and clinical care of infants with congenital heart disease (CHD), has shifted focus onto the accompanying and later-onset cognitive and neuropsychiatric disorders in those who also have 22q11.2 deletion syndrome (22qDS). 22qDS is itself associated with neurodevelopmental impairments and altered brain growth. However, when brain growth in 22qDS first deviates from normal is unknown, and whether impaired brain development is primarily genetics-driven or a secondary consequence of the underlying CHD remains incompletely understood. METHODS: In this small, exploratory study, we use fetal MRI to assess volumetric brain development in 22qDS by comparing fetal brain morphometry to a set of gestation and sex-matched healthy controls, and a cohort of gestation and sex-matched fetuses with the same CHD diagnoses but without 22q11.2 deletion. Structural T2-weighted fetal brain images were acquired using a 1.5T MRI scanner. MR scanner and sequence parameters were identical in all cohorts. Motion-corrected images underwent segmentation using an automated pipeline developed for fetal brain MRI. Total brain tissue volumes, volumes for four different tissue regions (cortical grey matter, white matter, deep grey matter and cerebellum), cerebrospinal fluid and total intracranial volumes were calculated. RESULTS: Antenatal imaging was acquired between 29 and 35 weeks gestation. Thirty-three fetuses were included (7 22qDS; 14 isolated CHD; 12 healthy control). White matter volumes were significantly reduced in fetuses with 22qDS compared to control fetuses (p = 0.028), but not to those with CHD without 22q11.2 deletion (p = 0.09). Large effect-sizes were seen between the 22qDS and isolated CHD cohorts (D(Cohen) = 0.81), and between the 22qDS and control cohorts (D(Cohen) = 1.2) for white matter volumes. No significant differences were seen in volumes of other brain regions between groups. CONCLUSIONS: This exploratory study expands our existing knowledge on neurodevelopmental impairments in 22qDS to the fetal period by highlighting reduced white matter volumes compared to gestation and sex-matched control fetuses during this time-period. Our findings suggest that impaired white matter growth in fetuses with both 22qDS and CHD may not be fully explained by any underlying CHD. |
| En ligne : |
https://dx.doi.org/10.1186/s11689-025-09594-9 |
| Permalink : |
https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=576 |
|  |
An exploratory fetal MRI study examining the impact of 22q11.2 microdeletion syndrome on early brain growth in Journal of Neurodevelopmental Disorders, 17 (2025)
